Cargando…
Update on the first-line treatment for Helicobacter pylori infection - a continuing challenge from an old enemy
Because the prevalence of antibiotic resistance markedly increases with time worldwide, anti-H. pylori treatment is continuing to be a great challenge forsphysicians in clinical practice. The Real-world Practice & Expectation of Asia-Pacific Physicians and Patients in Helicobacter Pylori Eradica...
Autores principales: | Huang, Chih-Chieh, Tsai, Kuo-Wang, Tsai, Tzung-Jiun, Hsu, Ping-I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505131/ https://www.ncbi.nlm.nih.gov/pubmed/28702193 http://dx.doi.org/10.1186/s40364-017-0103-x |
Ejemplares similares
-
Update on the first-line treatment of Helicobacter
pylori infection in areas with high and low clarithromycin
resistances
por: Shih, Chih-An, et al.
Publicado: (2022) -
First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017) -
Update on the second-line treatment of Helicobacter pylori infection: a narrative review
por: Shih, Chih-An, et al.
Publicado: (2023) -
The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012) -
First-line therapies for Helicobacter pylori eradication: a critical reappraisal of updated guidelines
por: De Francesco, Vincenzo, et al.
Publicado: (2017)